BRPI0919882A2 - métodos para avaliar padrões de rna - Google Patents
métodos para avaliar padrões de rnaInfo
- Publication number
- BRPI0919882A2 BRPI0919882A2 BRPI0919882A BRPI0919882A BRPI0919882A2 BR PI0919882 A2 BRPI0919882 A2 BR PI0919882A2 BR PI0919882 A BRPI0919882 A BR PI0919882A BR PI0919882 A BRPI0919882 A BR PI0919882A BR PI0919882 A2 BRPI0919882 A2 BR PI0919882A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- rna patterns
- evaluate rna
- evaluate
- patterns
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10974208P | 2008-10-30 | 2008-10-30 | |
| US11257108P | 2008-11-07 | 2008-11-07 | |
| US11405808P | 2008-11-12 | 2008-11-12 | |
| US11404508P | 2008-11-12 | 2008-11-12 | |
| US11406508P | 2008-11-13 | 2008-11-13 | |
| US15118309P | 2009-02-09 | 2009-02-09 | |
| US27804909P | 2009-10-02 | 2009-10-02 | |
| US25045409P | 2009-10-09 | 2009-10-09 | |
| US25302709P | 2009-10-19 | 2009-10-19 | |
| PCT/US2009/062880 WO2010062706A2 (en) | 2008-10-30 | 2009-10-30 | Methods for assessing rna patterns |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0919882A2 true BRPI0919882A2 (pt) | 2016-02-16 |
| BRPI0919882A8 BRPI0919882A8 (pt) | 2017-09-19 |
Family
ID=42226337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0919882A BRPI0919882A8 (pt) | 2008-10-30 | 2009-10-30 | Métodos para avaliar padrões de rna |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7888035B2 (pt) |
| EP (1) | EP2358912B1 (pt) |
| JP (1) | JP2012507300A (pt) |
| CN (1) | CN102308004A (pt) |
| BR (1) | BRPI0919882A8 (pt) |
| CA (1) | CA2742324A1 (pt) |
| IL (2) | IL212591A (pt) |
| WO (1) | WO2010062706A2 (pt) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| US8021847B2 (en) | 2004-06-02 | 2011-09-20 | Proxy Life Science Holdings, Inc. | Microvesicle-based compositions and methods |
| JP2008501336A (ja) * | 2004-06-02 | 2008-01-24 | ソースフアーム・インコーポレイテツド | Ｒｎａを含有する微小胞およびそのための方法 |
| CA2646329C (en) | 2006-03-20 | 2018-07-03 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| US8540752B2 (en) * | 2007-07-03 | 2013-09-24 | Spine Tek, Inc. | Interspinous mesh |
| US20100255514A1 (en) | 2007-08-16 | 2010-10-07 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
| CA2733672C (en) | 2007-08-16 | 2018-09-11 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
| WO2009032949A2 (en) | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| AU2008295394B2 (en) * | 2007-09-05 | 2014-04-24 | Laurentian University | Method of using tumour RNA integrity to measure response to chemotherapy in cancer patients |
| CA2700410C (en) * | 2007-10-03 | 2020-10-06 | Cornell University | Treatment of proliferative disorders using antibodies to psma |
| US20100069616A1 (en) * | 2008-08-06 | 2010-03-18 | The Regents Of The University Of California | Engineered antibody-nanoparticle conjugates |
| CA2735578C (en) | 2008-08-12 | 2018-10-23 | Zinfandel Pharmaceuticals, Inc. | Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants |
| US8846315B2 (en) | 2008-08-12 | 2014-09-30 | Zinfandel Pharmaceuticals, Inc. | Disease risk factors and methods of use |
| US7888035B2 (en) * | 2008-10-30 | 2011-02-15 | Caris Mpi, Inc. | Methods for assessing RNA patterns |
| US20140113310A9 (en) * | 2008-12-05 | 2014-04-24 | Myriad Genetics, Incorporated | Cancer detection markers |
| ES2712732T3 (es) * | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
| US20120231970A1 (en) * | 2009-09-30 | 2012-09-13 | Japan Health Sciences Foundation | Colon cancer marker and method for testing for colon cancer |
| EP2316972A1 (en) * | 2009-10-29 | 2011-05-04 | Deutsches Krebsforschungszentrum | Circulating miRNAs as non-invasive markers for diagnosis and staging in prostate cancer |
| CA2782284A1 (en) | 2009-11-30 | 2011-06-03 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems for isolating, storing, and analyzing vesicles |
| AU2010325969B2 (en) | 2009-12-02 | 2016-10-20 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen |
| WO2011106104A2 (en) * | 2010-02-26 | 2011-09-01 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for the detection and treatment of cancer involving mirnas and mirna inhibitors and targets |
| EP2542696B1 (en) | 2010-03-01 | 2016-09-28 | Caris Life Sciences Switzerland Holdings GmbH | Biomarkers for theranostics |
| JP2013526852A (ja) | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 疾患に対する循環バイオマーカー |
| WO2011156734A2 (en) * | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Method of characterizing vascular diseases |
| WO2011156763A1 (en) | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Methods for characterizing kidney function |
| IL243203A (en) | 2010-07-27 | 2017-04-30 | Genomic Health Inc | Method for using gene expression to determine prognosis of prostate cancer |
| EP3214185A1 (en) * | 2010-12-01 | 2017-09-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting the outcome of colon cancer by analysing mirna expression |
| EA201391017A1 (ru) | 2011-01-10 | 2014-04-30 | Зинфандел Фармасьютикалз, Инк. | Способы и готовые лекарственные формы для лечения болезни альцгеймера |
| WO2012135814A2 (en) * | 2011-03-31 | 2012-10-04 | University Of Houston | Microrna29a,b,c as a tumor suppressor and sensitizing agent for chemotherapy |
| EP2691548B1 (en) | 2011-03-31 | 2017-11-22 | University of Houston | Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy |
| JP6163479B2 (ja) | 2011-04-14 | 2017-07-12 | エクサレンズ バイオサイエンス リミテッド | 肝細胞癌の診断、予後診断、監視および治療方法 |
| JP6011945B2 (ja) * | 2011-05-20 | 2016-10-25 | 公一 中城 | マイクロｒｎａ又はその発現系を含む組成物 |
| JP5823031B2 (ja) | 2011-06-10 | 2015-11-25 | 日立化成株式会社 | 小胞捕捉デバイスおよびそれを用いるための方法 |
| JP2014519340A (ja) * | 2011-06-16 | 2014-08-14 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． | バイオマーカー組成物および方法 |
| WO2013020044A1 (en) | 2011-08-03 | 2013-02-07 | The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center | Treatment of fibrosis using microrna-19b |
| KR20140067001A (ko) * | 2011-08-08 | 2014-06-03 | 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. | 생물지표 조성물 및 방법 |
| US10590463B2 (en) | 2011-08-10 | 2020-03-17 | RNA Disgnostics Inc. | Diagnostic methods and kits for monitoring response to chemotherapy in ovarian cancer |
| EP3492606B1 (en) * | 2011-08-22 | 2023-10-04 | Exosome Diagnostics, Inc. | Urine biomarkers |
| WO2013038737A1 (ja) * | 2011-09-16 | 2013-03-21 | 北海道公立大学法人 札幌医科大学 | 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ |
| EP2833893B1 (en) * | 2012-04-03 | 2018-08-29 | Reneuron Limited | Stem cell microparticles |
| EP2653554A1 (en) * | 2012-04-17 | 2013-10-23 | Istituto Nazionale Di Genetica Molecolare-INGM | Immune response biomarkers |
| CN104640998B (zh) | 2012-04-24 | 2018-08-14 | Rna诊断公司 | 用于评估rna断裂的试验、方法和设备 |
| US8846316B2 (en) | 2012-04-30 | 2014-09-30 | Industrial Technology Research Institute | Biomarker for human liver cancer |
| WO2014030602A1 (ja) | 2012-08-20 | 2014-02-27 | 独立行政法人国立がん研究センター | 癌治療剤 |
| KR101933620B1 (ko) * | 2012-09-18 | 2018-12-28 | 삼성전자주식회사 | 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법 |
| US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
| EP4170031A1 (en) | 2012-10-23 | 2023-04-26 | Caris Science, Inc. | Aptamers and uses thereof |
| WO2014071226A1 (en) | 2012-11-02 | 2014-05-08 | The Regents Of The University Of California | Methods and systems for determining a likelihood of adverse prostate cancer pathology |
| CN102912030B (zh) * | 2012-11-08 | 2014-07-30 | 端鹏 | 用于前列腺癌早期诊断的引物对、探针和试剂盒 |
| AU2013354857B2 (en) | 2012-12-03 | 2019-05-02 | Rna Diagnostics Inc. | Methods and kits for monitoring response to radiation therapies in cancer |
| AU2013361323B2 (en) | 2012-12-19 | 2018-09-06 | Caris Science, Inc. | Compositions and methods for aptamer screening |
| KR101504817B1 (ko) * | 2013-04-05 | 2015-03-24 | 연세대학교 산학협력단 | 국소 진행형 위암에 대한 예후 예측 시스템 |
| WO2014182330A1 (en) | 2013-05-06 | 2014-11-13 | Hitachi Chemical Company Ltd | Devices and methods for capturing target molecules |
| CN104164474A (zh) * | 2013-05-17 | 2014-11-26 | 刘代新 | 一种检测尿液中pca3基因和psa基因表达量的荧光定量pcr法及其诊断试剂盒 |
| GB201317887D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product |
| CN105980615A (zh) * | 2013-08-28 | 2016-09-28 | 卡里斯生命科学瑞士控股有限公司 | 寡核苷酸探针及其用途 |
| US9550989B2 (en) * | 2013-10-03 | 2017-01-24 | Washington University | Rational design of microRNA-siRNA chimeras for multi-functional target suppression |
| US10731222B2 (en) | 2013-10-04 | 2020-08-04 | Rna Diagnostics Inc. | RNA disruption assay for predicting survival |
| GB201322034D0 (en) | 2013-12-12 | 2014-01-29 | Almac Diagnostics Ltd | Prostate cancer classification |
| CN103882118A (zh) * | 2014-02-13 | 2014-06-25 | 绍兴市人民医院 | 用于检测前列腺癌的miRNAs |
| EP4438743A3 (en) | 2014-05-30 | 2024-12-25 | Toray Industries, Inc. | Pancreatic cancer detection kit or device, and detection method |
| CN107076747B (zh) * | 2014-06-04 | 2021-02-02 | 阿托萨治疗学公司 | 分子乳房摄影术 |
| KR102761162B1 (ko) | 2014-06-12 | 2025-02-03 | 국립연구개발법인 고쿠리츠간켄큐센터 | 전립선암 검출 키트 또는 디바이스 및 검출 방법 |
| KR102511711B1 (ko) | 2014-06-13 | 2023-03-20 | 국립연구개발법인 고쿠리츠간켄큐센터 | 유방암 검출 키트 또는 디바이스 및 검출 방법 |
| EP4718079A2 (en) * | 2014-06-16 | 2026-04-01 | Toray Industries, Inc. | Stomach cancer biomarker and detection method |
| US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
| EP3218521B1 (en) | 2014-11-12 | 2019-12-25 | Hitachi Chemical Co., Ltd. | Method for diagnosing organ injury |
| WO2016090183A1 (en) * | 2014-12-03 | 2016-06-09 | Capricor Therapeutics, Inc. | Processes for producing stable exosome formulations |
| WO2016125243A1 (ja) * | 2015-02-03 | 2016-08-11 | 株式会社日立製作所 | エクソソーム測定方法及びエクソソーム抽出方法 |
| EP3314027A4 (en) | 2015-06-29 | 2019-07-03 | Caris Science, Inc. | THERAPEUTIC OLIGONUCLEOTIDES |
| US10941176B2 (en) | 2015-07-28 | 2021-03-09 | Caris Science, Inc. | Therapeutic oligonucleotides |
| US11254744B2 (en) | 2015-08-07 | 2022-02-22 | Imaginab, Inc. | Antigen binding constructs to target molecules |
| DE112016003948T5 (de) | 2015-08-31 | 2018-05-09 | City Of Sapporo | Molekulare verfahren zum beurteilen einer urothelialen erkrankung |
| US11753682B2 (en) | 2016-03-07 | 2023-09-12 | Father Flanagan's Boys'Home | Noninvasive molecular controls |
| US10731166B2 (en) | 2016-03-18 | 2020-08-04 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| CA3018048A1 (en) | 2016-03-31 | 2017-10-05 | Toray Industries, Inc. | Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor |
| WO2017205686A1 (en) | 2016-05-25 | 2017-11-30 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| US11266745B2 (en) | 2017-02-08 | 2022-03-08 | Imaginab, Inc. | Extension sequences for diabodies |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| CN108841962B (zh) * | 2018-08-01 | 2021-11-19 | 博奥生物集团有限公司 | 一种非小细胞肺癌检测试剂盒及其应用 |
| EP3835434A4 (en) | 2018-08-10 | 2022-06-08 | Toray Industries, Inc. | PROSTATE CANCER DETECTION KIT, DEVICE AND METHOD |
| CN111041081B (zh) * | 2018-10-11 | 2024-10-15 | 上海自然堂集团有限公司 | 一种以皮肤外源性老化靶标筛选活性物的方法及改善皮肤外源性老化的活性物 |
| CN109234362A (zh) * | 2018-10-15 | 2019-01-18 | 北京艾迪康医学检验实验室有限公司 | 检测样本中cltc-tfe3融合基因的寡核苷酸、方法和试剂盒 |
| CN109136379A (zh) * | 2018-10-15 | 2019-01-04 | 济南艾迪康医学检验中心有限公司 | 检测样本中NonO-TFE3融合基因的寡核苷酸、方法和试剂盒 |
| EP3888021B1 (en) | 2018-11-30 | 2024-02-21 | Caris MPI, Inc. | Next-generation molecular profiling |
| TWI758670B (zh) * | 2018-12-24 | 2022-03-21 | 奎克生技光電股份有限公司 | 健康風險評估方法 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| CN110305964B (zh) * | 2019-07-26 | 2023-03-21 | 安徽医科大学第一附属医院 | 一种前列腺癌患者预后复发风险预测标志工具及其风险评估模型的建立 |
| CA3163319A1 (en) | 2019-12-02 | 2021-06-10 | Caris Mpi, Inc. | Pan-cancer platinum response predictor |
| US20240117434A1 (en) * | 2021-02-18 | 2024-04-11 | The Johns Hopkins University | Methods and related aspects for detecting diseases, conditions, or disorders in subjects using extracelluar vesicles |
| US20240318242A1 (en) * | 2022-01-28 | 2024-09-26 | City University Of Hong Kong | Methods and systems for measuring multiplex rna expression |
| CA3254846A1 (en) * | 2022-06-10 | 2023-12-14 | City Of Hope | Biomarkers in pancreatic cancer |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3812023A (en) * | 1972-12-11 | 1974-05-21 | Reynolds Metals Co | Anodic production of pigmented siliceous coatings for aluminous metals |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
| US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| DE3924454A1 (de) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips) |
| EP0834575B1 (en) | 1990-12-06 | 2001-11-28 | Affymetrix, Inc. (a Delaware Corporation) | Identification of nucleic acids in samples |
| IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
| US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5554501A (en) | 1992-10-29 | 1996-09-10 | Beckman Instruments, Inc. | Biopolymer synthesis using surface activated biaxially oriented polypropylene |
| US5472672A (en) | 1993-10-22 | 1995-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for polymer synthesis using arrays |
| US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
| US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
| US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| US5658734A (en) | 1995-10-17 | 1997-08-19 | International Business Machines Corporation | Process for synthesizing chemical compounds |
| DE69739909D1 (de) | 1996-03-26 | 2010-07-29 | Michael S Kopreski | Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden |
| FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
| FR2788780B1 (fr) | 1999-01-27 | 2001-03-30 | Ap Cells Inc | Procede de preparation de vesicules membranaires |
| GB9927320D0 (en) | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
| US20040241176A1 (en) | 2000-04-27 | 2004-12-02 | Ap Cells. Inc. | Method of producing membrane vesicles |
| US6812023B1 (en) | 2000-04-27 | 2004-11-02 | Anosys, Inc. | Methods of producing membrane vesicles |
| IL160142A0 (en) | 2001-08-17 | 2004-06-20 | Anosys Inc | Methods and compounds for the targeting of protein to exosomes |
| US20070203333A1 (en) | 2001-11-30 | 2007-08-30 | Mcswiggen James | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| AUPS187002A0 (en) * | 2002-04-22 | 2002-05-30 | Queensland University Of Technology | Condition-specific molecules and uses therefor |
| CA2504605C (en) | 2002-11-13 | 2016-01-19 | Thomas Jefferson University | Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| JP4939926B2 (ja) | 2003-02-14 | 2012-05-30 | アノシス・インコーポレーテッド | 抗体を生成し抗体レパートリーをスクリーニングするための方法とコンパウンド |
| GB0318096D0 (en) | 2003-08-01 | 2003-09-03 | Queen Mary & Westfield College | Vaccine |
| CA2453198A1 (en) | 2004-01-07 | 2005-07-07 | Wei-Ping Min | Quantification and generation of immune suppressive exosomes |
| JP5068543B2 (ja) | 2004-02-16 | 2012-11-07 | プロテオジス アクチェンゲゼルシャフト | がんに関する診断マーカー |
| JP2008501336A (ja) | 2004-06-02 | 2008-01-24 | ソースフアーム・インコーポレイテツド | Ｒｎａを含有する微小胞およびそのための方法 |
| CA2491067A1 (en) * | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
| US20060211000A1 (en) * | 2005-03-21 | 2006-09-21 | Sorge Joseph A | Methods, compositions, and kits for detection of microRNA |
| CN103820562B (zh) | 2005-08-01 | 2015-05-13 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
| US20070092882A1 (en) | 2005-10-21 | 2007-04-26 | Hui Wang | Analysis of microRNA |
| US7197923B1 (en) * | 2005-11-07 | 2007-04-03 | Halliburton Energy Services, Inc. | Single phase fluid sampler systems and associated methods |
| US7670840B2 (en) | 2006-01-05 | 2010-03-02 | The Ohio State University Research Foundation | Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors |
| EP1969147B1 (en) | 2006-01-05 | 2014-07-30 | The Ohio State University Research Foundation | microRNA-based methods for the diagnosis of stomach cancer |
| ES2553442T3 (es) | 2006-01-05 | 2015-12-09 | The Ohio State University Research Foundation | Procedimientos basados en los microARN para el diagnóstico, pronóstico y tratamiento del cáncer de pulmón |
| US7593913B2 (en) | 2006-01-11 | 2009-09-22 | Siemens Medical Solutions Usa, Inc. | Systems and method for integrative medical decision support |
| EP1994410B1 (en) | 2006-01-31 | 2010-10-27 | Medical Research Fund of Tel Aviv Sourasky Medical Center | Methods for early detection of cancer |
| US9198981B2 (en) | 2006-02-01 | 2015-12-01 | The University Of Kentucky | Modulation of angiogenesis |
| EP2522746B1 (en) | 2006-03-02 | 2014-11-12 | The Ohio State University Research Foundation | MicroRNA expression profile associated with pancreatic cancer |
| DK3517151T3 (da) | 2006-03-09 | 2021-07-12 | Aethlon Medical Inc | Ekstrakorporal fjernelse af mikrovesikulære partikler |
| US9085778B2 (en) | 2006-05-03 | 2015-07-21 | VL27, Inc. | Exosome transfer of nucleic acids to cells |
| EP2589668A1 (en) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Rare cell analysis using sample splitting and DNA tags |
| US7462489B2 (en) | 2006-11-09 | 2008-12-09 | Ley Klaus F | Methods for identifying and analyzing biomarkers from plasma-derived microparticles |
| US20100055723A1 (en) | 2007-01-23 | 2010-03-04 | University Of Virginia Patent Foundation | Galectin-3-Binding Protein as a Biomarker of Cardiovascular Disease |
| CN101641010A (zh) | 2007-01-26 | 2010-02-03 | 路易斯维尔大学研究基金会公司 | 用作疫苗的外来体组分的修饰 |
| US8314220B2 (en) * | 2007-01-26 | 2012-11-20 | Agilent Technologies, Inc. | Methods compositions, and kits for detection of microRNA |
| ATE535805T1 (de) | 2007-01-26 | 2011-12-15 | Univ Louisville Res Found | Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen |
| WO2008094545A2 (en) | 2007-01-31 | 2008-08-07 | The Ohio State University Research Foundation | Mic orna-based methods and compositions for the treatment of acute myeloid leukemia |
| WO2008112283A2 (en) | 2007-03-12 | 2008-09-18 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment |
| AU2008231393A1 (en) * | 2007-03-27 | 2008-10-02 | Rosetta Genomics Ltd. | Gene expression signature for classification of cancers |
| WO2008138578A2 (en) | 2007-05-11 | 2008-11-20 | Medical Prognosis Institute | Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| CA2676113C (en) | 2007-07-25 | 2014-07-08 | University Of Louisville Research Foundation, Inc. | Exosome-associated microrna as a diagnostic marker |
| WO2009019215A1 (en) | 2007-08-03 | 2009-02-12 | Dkfz Deutsches Krebsforschungszentrum | Method for prenatal diagnosis using exosomes and cd24 as a marker |
| CA2733672C (en) | 2007-08-16 | 2018-09-11 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
| EP2610342B1 (en) | 2007-09-14 | 2016-05-04 | The Ohio State University Research Foundation | MiRNA Expression in Human Peripheral Blood Microvesicles and uses Thereof |
| US8895525B2 (en) | 2007-10-29 | 2014-11-25 | University Of Southern California | Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic RNAs |
| CN101918594A (zh) | 2007-11-30 | 2010-12-15 | 俄亥俄州立大学研究基金会 | 肺癌中外周血中的微rna表达特征谱和靶向 |
| US8617806B2 (en) | 2008-01-25 | 2013-12-31 | Hansabiomed Ou | Method to measure and characterize microvesicles in the human body fluids |
| CA2713469A1 (en) | 2008-02-01 | 2009-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions relating to carcinoma stem cells |
| KR101810799B1 (ko) | 2008-02-01 | 2017-12-19 | 더 제너럴 하스피탈 코포레이션 | 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도 |
| CN102027129B (zh) | 2008-02-28 | 2014-03-12 | 俄亥俄州立大学研究基金会 | 用于前列腺相关病症的诊断、预后和治疗的基于微rna的方法和组合物 |
| WO2009147519A1 (en) | 2008-06-06 | 2009-12-10 | Centre National De La Recherche Scientifique - Cnrs- | Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| JP2011525114A (ja) | 2008-06-20 | 2011-09-15 | プロキシ ライフ サイエンス ホールディングス インコーポレイテッド | 微小胞組織に基づく組成物および方法 |
| EP2334339A4 (en) | 2008-09-18 | 2012-09-26 | Univ Ohio State Res Found | DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES OF MIR IN ADAPTIVE PATHWAYS AND / OR PATHOLOGICAL PATHWAYS |
| US10545149B2 (en) | 2008-10-06 | 2020-01-28 | Morehouse School Of Medicine | Detection of HIV-related proteins in urine |
| US7888035B2 (en) * | 2008-10-30 | 2011-02-15 | Caris Mpi, Inc. | Methods for assessing RNA patterns |
| WO2010056337A2 (en) * | 2008-11-12 | 2010-05-20 | Caris Mpi, Inc. | Methods and systems of using exosomes for determining phenotypes |
| GB0822836D0 (en) | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
-
2009
- 2009-10-30 US US12/609,847 patent/US7888035B2/en not_active Expired - Fee Related
- 2009-10-30 EP EP09829654.4A patent/EP2358912B1/en active Active
- 2009-10-30 WO PCT/US2009/062880 patent/WO2010062706A2/en not_active Ceased
- 2009-10-30 BR BRPI0919882A patent/BRPI0919882A8/pt not_active IP Right Cessation
- 2009-10-30 CN CN2009801505509A patent/CN102308004A/zh active Pending
- 2009-10-30 CA CA 2742324 patent/CA2742324A1/en not_active Abandoned
- 2009-10-30 JP JP2011534831A patent/JP2012507300A/ja active Pending
-
2010
- 2010-12-08 US US12/963,468 patent/US8192954B2/en not_active Expired - Fee Related
-
2011
- 2011-04-28 IL IL21259111A patent/IL212591A/en not_active IP Right Cessation
-
2012
- 2012-07-06 US US13/543,101 patent/US20130045882A1/en not_active Abandoned
-
2014
- 2014-06-17 IL IL233188A patent/IL233188A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20110159506A1 (en) | 2011-06-30 |
| CA2742324A1 (en) | 2010-06-03 |
| EP2358912A4 (en) | 2012-10-31 |
| EP2358912A2 (en) | 2011-08-24 |
| BRPI0919882A8 (pt) | 2017-09-19 |
| IL212591A0 (en) | 2011-07-31 |
| US20100113290A1 (en) | 2010-05-06 |
| WO2010062706A3 (en) | 2010-09-02 |
| CN102308004A (zh) | 2012-01-04 |
| US20130045882A1 (en) | 2013-02-21 |
| JP2012507300A (ja) | 2012-03-29 |
| US8192954B2 (en) | 2012-06-05 |
| WO2010062706A2 (en) | 2010-06-03 |
| IL233188A0 (en) | 2014-07-31 |
| IL233188A (en) | 2016-05-31 |
| US7888035B2 (en) | 2011-02-15 |
| IL212591A (en) | 2014-07-31 |
| EP2358912B1 (en) | 2016-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0919882A2 (pt) | métodos para avaliar padrões de rna | |
| BRPI0817547A2 (pt) | Método para realizar pirólise | |
| BRPI0919426A2 (pt) | métodos melhorado de exposição de rna | |
| BRPI0914054A2 (pt) | método para produzir etilenoaminas | |
| BRPI0919116A2 (pt) | método | |
| PT2231689T (pt) | Novos nucleósidos 7-deazapurina citostáticos | |
| BRPI0916973A2 (pt) | anticorpos para ccr2 | |
| SMT201400100B (it) | Processo migliorato | |
| EP2499661A4 (en) | PHOTO PAINT SIMULATION | |
| BRPI0914614A2 (pt) | 2-arilaminoquinazolinas para tratar doenças proliferativas | |
| BRPI0822695A2 (pt) | Processo para produzir um isocianato | |
| DK2313489T3 (da) | Fremstillingsmetode | |
| BRPI0922490A2 (pt) | Método para produção de beta-santaleno | |
| BRPI0822694A2 (pt) | Processo para produzir um isocianato | |
| BRPI0918157A2 (pt) | acessório em y para raspa-tubos | |
| BRPI0909488A2 (pt) | brocha | |
| BRPI0911625A2 (pt) | Métodos | |
| BRPI0819633A2 (pt) | Métodos para produzir poliolefinas | |
| BR112012009097A2 (pt) | processo para produzir colagens | |
| BRPI0908778A2 (pt) | Processo para produzir material de carbono | |
| BRPI0818678A2 (pt) | Processo para preparar eteno | |
| BRPI1013718A2 (pt) | processo integrado para produzir hidrocarbonetos | |
| BRPI0814117A2 (pt) | Método para ativar catalisador para produção de cloro | |
| BRPI0916597A2 (pt) | Método | |
| BRPI0912435A2 (pt) | processo melhorado para telomerizar butadieno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: CARIS LIFE SCIENCES SWITZERLAND HOLDINGS GMBH (CH) |
|
| B25G | Requested change of headquarter approved |
Owner name: CARIS LIFE SCIENCES SWITZERLAND HOLDINGS GMBH (CH) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |